Rapid Micro Biosystem’s innovative Growth Direct System^® platform is the only system to automate the compendial method of microbial quality control (QC) in the manufacture of healthcare products. The Growth Direct System fully automates traditional microbial testing – detects contamination more quickly, delivering compelling economic benefits, while improving quality control processes and data integrity.

Rapid Micro Biosystems (NASDAQ:RPID) is based in Lowell, MA (US) and has a growing customer base in the US, Europe and Asia.